First Advantage Co. (NYSE:FA) Shares Sold by Norwood Investment Partners LP

Norwood Investment Partners LP lessened its holdings in shares of First Advantage Co. (NYSE:FA - Free Report) by 59.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 232,222 shares of the company's stock after selling 336,593 shares during the period. First Advantage comprises approximately 2.9% of Norwood Investment Partners LP's investment portfolio, making the stock its 12th biggest position. Norwood Investment Partners LP owned 0.13% of First Advantage worth $3,272,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Signaturefd LLC bought a new stake in shares of First Advantage during the first quarter valued at approximately $30,000. Cornerstone Planning Group LLC bought a new position in First Advantage in the first quarter worth approximately $63,000. GAMMA Investing LLC raised its stake in First Advantage by 748.5% in the first quarter. GAMMA Investing LLC now owns 6,890 shares of the company's stock worth $97,000 after buying an additional 6,078 shares in the last quarter. Summit Investment Advisors Inc. raised its stake in First Advantage by 15.3% in the fourth quarter. Summit Investment Advisors Inc. now owns 6,267 shares of the company's stock worth $117,000 after buying an additional 832 shares in the last quarter. Finally, BNP Paribas Financial Markets bought a new position in First Advantage in the fourth quarter worth approximately $132,000. Hedge funds and other institutional investors own 94.91% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on FA. Royal Bank Of Canada downgraded shares of First Advantage from an "outperform" rating to a "sector perform" rating and set a $20.00 price objective for the company. in a research note on Friday, May 9th. Needham & Company LLC reissued a "hold" rating on shares of First Advantage in a research note on Monday, June 2nd. Finally, Barclays upped their price target on First Advantage from $15.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Thursday, May 29th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $20.25.

First Advantage Stock Up 0.2%

Shares of FA stock traded up $0.04 during trading hours on Friday, reaching $18.40. 725,725 shares of the company's stock were exchanged, compared to its average volume of 1,087,528. The stock's 50 day moving average is $17.44 and its 200-day moving average is $16.54. The company has a market cap of $3.20 billion, a price-to-earnings ratio of 613.33 and a beta of 1.24. The company has a current ratio of 3.85, a quick ratio of 3.85 and a debt-to-equity ratio of 0.61. First Advantage Co. has a fifty-two week low of $12.32 and a fifty-two week high of $20.79.

First Advantage (NYSE:FA - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.13 by $0.04. First Advantage had a net margin of 0.65% and a return on equity of 13.16%. The firm's quarterly revenue was up 109.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.17 EPS. Analysts predict that First Advantage Co. will post 0.74 earnings per share for the current fiscal year.

About First Advantage

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.